Epiq Capital Group, Llc - Net Worth and Insider Trading
Epiq Capital Group, Llc Net Worth
The estimated net worth of Epiq Capital Group, Llc is at least $7 Million dollars as of 2024-11-08. Epiq Capital Group, Llc is the of Quince Therapeutics Inc and owns about 2,860,967 shares of Quince Therapeutics Inc (QNCX) stock worth over $5 Million. Epiq Capital Group, Llc is the of Applied Molecular Transport Inc and owns about 8,337,518 shares of Applied Molecular Transport Inc (AMTI) stock worth over $2 Million. Epiq Capital Group, Llc is also the 10% Owner of Lucira Health Inc and owns about 3,461,764 shares of Lucira Health Inc (LHDXQ) stock worth over $346. Details can be seen in Epiq Capital Group, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Epiq Capital Group, Llc has not made any transactions after 2022-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Epiq Capital Group, Llc
Epiq Capital Group, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Epiq Capital Group, Llc owns 3 companies in total, including Quince Therapeutics Inc (QNCX) , Applied Molecular Transport Inc (AMTI) , and Lucira Health Inc (LHDXQ) .
Click here to see the complete history of Epiq Capital Group, Llc’s form 4 insider trades.
Insider Ownership Summary of Epiq Capital Group, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2020-06-12 | other: IA/Managing Member 10% owner |
| AMTI | Applied Molecular Transport Inc | 2022-05-13 | other: Managing member of 10% owner |
| LHDXQ | Lucira Health Inc | 2022-12-14 | 10 percent owner |
Epiq Capital Group, Llc Latest Holdings Summary
Epiq Capital Group, Llc currently owns a total of 3 stocks. Among these stocks, Epiq Capital Group, Llc owns 2,860,967 shares of Quince Therapeutics Inc (QNCX) as of June 12, 2020, with a value of $5 Million and a weighting of 67.59%. Epiq Capital Group, Llc owns 8,337,518 shares of Applied Molecular Transport Inc (AMTI) as of May 13, 2022, with a value of $2 Million and a weighting of 32.4%. Epiq Capital Group, Llc also owns 3,461,764 shares of Lucira Health Inc (LHDXQ) as of February 5, 2021, with a value of $346 and a weighting of 0.01%.
Latest Holdings of Epiq Capital Group, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2020-06-12 | 2,860,967 | 1.60 | 4,574,400 |
| AMTI | Applied Molecular Transport Inc | 2022-05-13 | 8,337,518 | 0.26 | 2,192,767 |
| LHDXQ | Lucira Health Inc | 2021-02-05 | 3,461,764 | 0.00 | 346 |
Holding Weightings of Epiq Capital Group, Llc
Epiq Capital Group, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Epiq Capital Group, Llc has made a total of 2 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 9,040 shares on June 12, 2020, which cost Epiq Capital Group, Llc around $400,020.
According to the SEC Form 4 filings, Epiq Capital Group, Llc has made a total of 3 transactions in Applied Molecular Transport Inc (AMTI) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Applied Molecular Transport Inc is the acquisition of 62,143 shares on May 13, 2022, which cost Epiq Capital Group, Llc around $249,815.
According to the SEC Form 4 filings, Epiq Capital Group, Llc has made a total of 1 transactions in Lucira Health Inc (LHDXQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lucira Health Inc is the acquisition of 3,461,764 shares on February 5, 2021, which cost Epiq Capital Group, Llc around $59 Million.
Insider Trading History of Epiq Capital Group, Llc
- 1
Epiq Capital Group, Llc Trading Performance
GuruFocus tracks the stock performance after each of Epiq Capital Group, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Epiq Capital Group, Llc is -13.72%. GuruFocus also compares Epiq Capital Group, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Epiq Capital Group, Llc within 3 months outperforms 3 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Epiq Capital Group, Llc's insider trading performs compared to the benchmark.
Performance of Epiq Capital Group, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.19 | | | | | |
| Relative Return to S&P 500(%) | -8 | | | | | |
Epiq Capital Group, Llc Ownership Network
Ownership Network List of Epiq Capital Group, Llc
Ownership Network Relation of Epiq Capital Group, Llc
Epiq Capital Group, Llc Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Epiq Capital Group, Llc is the other: IA/Managing Member 10% owner of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Epiq Capital Group, Llc made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Epiq Capital Group, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Epiq Capital Group, Llc. You might contact Epiq Capital Group, Llc via mailing address: One Lombard Street, Suite 200, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
